Vyome (HIND) Proxy Filing summary

Executive summary

• The annual meeting is scheduled for October 28, 2025, to vote on director elections, an equity incentive plan, auditor ratification, and executive compensation.

• The board recommends voting in favor of all proposals and provides detailed instructions for voting by internet, phone, or mail.

• The proxy statement includes forward-looking statements regarding business operations, financial performance, and executive compensation.

Voting matters and shareholder proposals

• Proposals include electing three Class I directors, approving the 2025 Equity Incentive Plan, ratifying Kreit & Chiu CPA LLP as auditor, and an advisory vote on executive compensation.

• Shareholders may submit proposals for the 2026 annual meeting by June 30, 2026, following SEC and bylaw requirements.

• The board recommends voting “FOR” all proposals.

Board of directors and corporate governance

• The board consists of six members, with staggered three-year terms and specific designation rights per the merger agreement.

• Committees include audit, compensation, nominating and governance, and an AI committee focused on healthcare AI initiatives.

• Four directors are deemed independent under SEC and Nasdaq rules.

• A code of business conduct and ethics applies to all employees, officers, and directors.